Brind.

ATM facility supported a capital raise while Codexis advanced its path toward GMP-grade siRNA.

1 report, 1 independent Updated Aug 14

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

ATM Codexis

Keep exploring

The entities involved

ATM
public transport company of Milan

Nothing else this week.
Codexis
American protein engineering company
- Codexis advanced production with its partner/product Synthesis.Mon 11:07
- Codexis has reached an agreement to explore stereo-defined fragment synthesis as part of its advanced production strategy.Mon 11:07

Coverage

Newest first; wire copies grouped

Aug 14GlobeNewswireCodexis Reports Second Quarter 2025 Financial Results Announces revenue of $15.3M vs $14.1M analyst consensus estimate Six presentations featured ECO Synthesis® platform at 2025 TIDES USA annual meet